3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Synovitis, Pigmented Villonodular
1
Synovitis
1
Solid Cancers
1
Ovarian Neoplasms
1
Lymphoma, Non-Hodgkin
1
Fallopian Tube Neoplasms
1
Brenner Tumor
1
Advanced Solid Tumors
1
Interventions
pexidartinib
3
nilotinib
2
emactuzumab
1
cabiralizumab
1
Tolbutamide
1
Midazolam
1
Bro protein, Drosophila
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Synovitis, Pigmented Villonodular
×
emactuzumab
×
Clear all
NCT05417789
2026-02-02
TANGENT
SynOx Therapeutics Limited
Phase 3
Active not recruiting
128 enrolled